Published in Neurology on September 27, 2011
The role of B vitamins in preventing and treating cognitive impairment and decline. Adv Nutr (2012) 1.18
B Vitamins and the Brain: Mechanisms, Dose and Efficacy-A Review. Nutrients (2016) 0.99
Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the Women's Health Initiative Memory Study. J Acad Nutr Diet (2014) 0.82
Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness. Alzheimers Dement (2016) 0.80
Diet and Neuroimaging Markers of Cerebrovascular Disease. Curr Nutr Rep (2013) 0.79
Natural products and supplements for geriatric depression and cognitive disorders: an evaluation of the research. Curr Psychiatry Rep (2014) 0.77
Diffusion tensor tractography and neuropsychological assessment in patients with vitamin B12 deficiency. Neuroradiology (2013) 0.76
Causes, Consequences and Public Health Implications of Low B-Vitamin Status in Ageing. Nutrients (2016) 0.75
Reducing occupational stress with a B-vitamin focussed intervention: a randomized clinical trial: study protocol. Nutr J (2014) 0.75
Folate and Vitamin B12-Related Biomarkers in Relation to Brain Volumes. Nutrients (2016) 0.75
Correlation of Tc-99 m ethyl cysteinate dimer single-photon emission computed tomography and clinical presentations in patients with low cobalamin status. BMC Neurol (2015) 0.75
Remission of cognitive deficits in Parkinson's disease: recovery from a nonamnestic mild cognitive impairment or psychiatric symptoms remission? Case Rep Psychiatry (2012) 0.75
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med (2002) 11.20
Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging (2005) 5.84
Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke (2004) 3.80
Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. J Comput Assist Tomogr (1992) 3.62
Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis (2003) 3.36
Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology (2006) 3.00
Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study. Neuropsychologia (2003) 2.68
How common is vitamin B-12 deficiency? Am J Clin Nutr (2008) 2.37
Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol (2002) 2.30
High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr (2005) 2.18
A 44-month clinical-brain MRI follow-up in a patient with B12 deficiency. Neurology (1997) 2.04
Local histogram correction of MRI spatially dependent image pixel intensity nonuniformity. J Magn Reson Imaging (1996) 2.01
Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr (2007) 1.98
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One (2010) 1.92
Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke (2005) 1.91
Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry (1996) 1.90
Clinical relevance of low serum vitamin B12 concentrations in older people: the Banbury B12 study. Age Ageing (2006) 1.86
Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. FASEB J (1993) 1.85
Age-related differences in volumes of subcortical nuclei, brain matter, and cerebrospinal fluid in healthy men as measured with magnetic resonance imaging. Arch Neurol (1992) 1.70
Elevation of 2-methylcitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency. Metabolism (1993) 1.62
Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol (2008) 1.60
Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol (2003) 1.55
White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology (2010) 1.44
Lack of age-related differences in temporal lobe volume of very healthy adults. AJNR Am J Neuroradiol (1994) 1.41
Biracial population study of mortality in mild cognitive impairment and Alzheimer disease. Arch Neurol (2009) 1.40
Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology (2008) 1.39
Low vitamin B-12 status and risk of cognitive decline in older adults. Am J Clin Nutr (2007) 1.32
Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. Stroke (1999) 1.15
Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline. Neurology (2009) 1.14
Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study. Neurology (2004) 1.11
The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. Arch Neurol (2010) 1.05
Cobalamin (vitamin B(12)) in subacute combined degeneration and beyond: traditional interpretations and novel theories. Exp Neurol (2005) 1.02
Plasma vitamin B12 status and cerebral white-matter lesions. J Neurol Neurosurg Psychiatry (2008) 0.99
Plasma folate concentration and cognitive performance: Rotterdam Scan Study. Am J Clin Nutr (2007) 0.95
Apolipoprotein E, B vitamins, and cognitive function in older adults. J Gerontol B Psychol Sci Soc Sci (2005) 0.84
Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients. J Neurol Sci (2009) 0.81
Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health (1993) 11.92
Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet (1994) 10.14
Modular chemistry: secondary building units as a basis for the design of highly porous and robust metal-organic carboxylate frameworks. Acc Chem Res (2001) 9.19
Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology (2006) 8.97
Regulatory element detection using correlation with expression. Nat Genet (2001) 8.92
Notch signalling controls pancreatic cell differentiation. Nature (1999) 7.18
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature (1996) 7.11
Refined structure of alpha beta-tubulin at 3.5 A resolution. J Mol Biol (2001) 7.08
An improved and simplified method of detecting the acetylator phenotype. J Med Genet (1969) 6.40
Mechanical unfolding intermediates in titin modules. Nature (1999) 6.12
Natural history of mild cognitive impairment in older persons. Neurology (2002) 6.09
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene (2006) 5.86
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology (2005) 5.76
A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet (1980) 5.68
Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord (2001) 5.09
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest (2001) 4.98
An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae. Appl Environ Microbiol (2001) 4.59
MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging (2001) 4.54
Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci (1991) 4.53
A mouse model for spinal muscular atrophy. Nat Genet (2000) 4.37
Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br Med J (1969) 4.21
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection. J Virol (2007) 4.13
Latent Semantic Indexing of medical diagnoses using UMLS semantic structures. Proc Annu Symp Comput Appl Med Care (1991) 4.09
Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology (2012) 4.09
Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res (2001) 3.89
PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol (2000) 3.81
Maintaining mobility in late life. I. Demographic characteristics and chronic conditions. Am J Epidemiol (1993) 3.74
Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology (2006) 3.71
Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res (1999) 3.69
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology (2004) 3.61
Nomenclature for N-acetyltransferases. Pharmacogenetics (1995) 3.59
Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology (2003) 3.59
Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med (1996) 3.48
Established populations for epidemiologic studies of the elderly: study design and methodology. Aging (Milano) (1993) 3.47
Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet (2004) 3.45
Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology (2002) 3.40
Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br (1982) 3.39
Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med (1999) 3.38
Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology (2003) 3.35
Proton-pump inhibitors and risk of fractures: an update meta-analysis. Osteoporos Int (2016) 3.30
Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell (1998) 3.20
Building a dictionary for genomes: identification of presumptive regulatory sites by statistical analysis. Proc Natl Acad Sci U S A (2000) 3.18
Structure of translation factor eIF4E bound to m7GDP and interaction with 4E-binding protein. Nat Struct Biol (1997) 3.14
Age-specific incidence of Alzheimer's disease in a community population. JAMA (1995) 3.09
Hormone-dependent, CARM1-directed, arginine-specific methylation of histone H3 on a steroid-regulated promoter. Curr Biol (2001) 3.09
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol (1999) 3.08
Mechanical design of proteins studied by single-molecule force spectroscopy and protein engineering. Prog Biophys Mol Biol (2000) 3.00
TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation. Oncogene (2008) 2.94
Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med (1992) 2.92
Identification of coryneform bacterial isolates by ribosomal DNA sequence analysis. J Clin Microbiol (2000) 2.87
Validation of near-infrared spectroscopy in humans. J Appl Physiol (1985) (1994) 2.77
Cognitive activity and incident AD in a population-based sample of older persons. Neurology (2002) 2.77
tRNA splicing. J Biol Chem (1998) 2.77
Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. J Neurosurg (1998) 2.75
Feasibility of a high-speed gamma-camera design using the high-yield-pileup-event-recovery method. J Nucl Med (2001) 2.69
Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry (2004) 2.67
A prospective study of incident comprehensive medical home care use among the elderly. Am J Public Health (1988) 2.67
Social resources and cognitive decline in a population of older African Americans and whites. Neurology (2004) 2.66
Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev (1995) 2.61
Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology (2003) 2.60
Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell (1999) 2.58
Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet (1999) 2.57
Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci U S A (2001) 2.56
Fps1p controls the accumulation and release of the compatible solute glycerol in yeast osmoregulation. Mol Microbiol (1999) 2.52
LIM homeodomain factors Lhx3 and Lhx4 assign subtype identities for motor neurons. Cell (1998) 2.50
Change in body mass index and risk of incident Alzheimer disease. Neurology (2005) 2.48
Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology (2006) 2.48
Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol Life Sci (2005) 2.47
Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int (2007) 2.44
Cognitive decline in incident Alzheimer disease in a community population. Neurology (2010) 2.41
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes (1999) 2.36
Changing sexual attitudes and behaviour in China: implications for the spread of HIV and other sexually transmitted diseases. AIDS Care (1999) 2.35
An Arabidopsis mutant defective in the plastid general protein import apparatus. Science (1998) 2.35
Model-based methods for identifying periodically expressed genes based on time course microarray gene expression data. Bioinformatics (2004) 2.32
Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology (2003) 2.32
Cognitive activity in older persons from a geographically defined population. J Gerontol B Psychol Sci Soc Sci (1999) 2.31
Structure of a cytochrome P450-redox partner electron-transfer complex. Proc Natl Acad Sci U S A (1999) 2.30
Parkinsonian signs in subjects with mild cognitive impairment. Neurology (2005) 2.30
MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging (2004) 2.29
Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J Natl Cancer Inst (2000) 2.27
Correlates of cognitive function in an elderly community population. Am J Epidemiol (1988) 2.26